{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-029363","form_type":"8-K","ticker":"BCTX","cik":"0001610820","company_name":"BriaCell Therapeutics Corp.","filed_at":"2025-12-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.914660+00:00","generated_at":"2026-05-16T12:06:42.124979+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BriaPro subsidiary posts Q1 operating loss $258K, R&D spend jumps 5x, going concern doubt","bullets":["Net loss $244,738 for three months ended Oct 31, 2025, vs $82,123 prior year; operating loss $258,445.","R&D expenses surged to $237,501 from $48,500, driven by wages $161,875 and supplies $75,626.","Cash remains $1; total assets $180,708; current liabilities $1,403,120 (including $1.31M due to parent BriaCell).","Shareholders' deficit $1,390,648; accumulated deficit $1,425,163; going concern uncertainty noted as dependent on BriaCell funding.","No auditor review performed; warrants liability $168,236 with Black-Scholes valuation."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-029363","json":"https://secwatch.observer/filing/0001493152-25-029363.json","markdown":"https://secwatch.observer/filing/0001493152-25-029363.md","text":"https://secwatch.observer/filing/0001493152-25-029363.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225029363/0001493152-25-029363-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610820/000149315225029363/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:06:42.124979+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}